<i>Igf1r</i> deficiency decreases airway inflammation and remodeling after HDM exposure. by Sergio Piñeiro-Hermida (837279)

NO measurement after BPP-BrachyNH₂ addition on endothelium-intact rat aorta cross sections assessed by using a confocal scanning laser microscope. by Daniel Dias Rufino Arcanjo (536744)

Female bitransgenic mice show abnormal spontaneous physical activity and decreased oxygen consumption and body temperature. by Dongmei Wu (215055)

“…(C) Oxygen consumption decreased in female bitransgenic mice at 12 months of age, <i>n</i> = 7 for each group at the age of 4-month old, <i>n</i> = 5 for each group at the age of 12-month old. …”

Fluoxetine decreases TOPFlash firefly luciferase reporter activity. by Kentaro Miyamoto (123271)

HFD Developmentally Decreases B Lymphopoiesis: RT-PCR was performed on whole BM extracted from the femur. by Benjamin J. Adler (417336)

“…(c) Pax-5 expression, which represents an intermediate step in B lymphopoiesis did not appear reduced at 2D, but was significantly decreased subsequently. …”

Blockade of Tim-3 pathway increased IFN-γ production and decreased apoptosis of NK cells in vitro. by Hongyan Hou (482201)

Ppk1 levels are not affected by decreasing dendrite arbor size but are reduced when dendrite length increases. by Josephine W. Mitchell (17364781)

A647D mutation decreases I_Na of WT and P1332L when co-expressed. by Jie Liu (15128)

Male exposure in ewes decreased the content of <i>Tac2</i> mRNA in the rostral ARC. by Julie-Ann P. De Bond (383668)

Supplementary Material for: Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times by Lannes F. (11465377)

“…There was no significant difference between groups for 90-day readmission (<i>p</i> = 0.349). Mean length of stay did not differ significantly between ERAS and non-ERAS groups (12.7 ± 6.2 and 13.1 ± 5.7 days, respectively; <i>p</i> = 0.743). …”

Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia. by Qinyu Luo (13000956)

Data_Sheet_1_Risk of psychological distress by decrease in economic activity, gender, and age due to COVID-19: A multinational study.PDF by Minji Kim (1722313)

“…With 7,090 of female (49.8%), mean age 40.67, 5,734 (12.75%) lost their job and 5,734 (40.26%) suffered from psychological distress.…”

The frequency of MHV68 infection in mature B cells is decreased in mice depleted of developing B cells. by Carrie B. Coleman (584493)

Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia. by Qinyu Luo (13000956)

Pirfenidone stabilized the mitochondrial membrane potential (MMP) and decreased intracellular ROS in renal proximal tubular cells. by Jun-Feng Chen (494741)

Expression of <i>mrpAB</i>, CDR1913–1914, or CDR1929 decreases swimming motility. by Anchal Mehra (21402835)

Decreased E/I synapse ratio and loss of cortico-LA synaptic plasticity in the absence of coronin 1. by Rajesh Jayachandran (542641)

“…Scale bar, 2 microns. Data shown are mean values ± SD, <i>p</i><0.01. (C) Hippocampal neurons were labeled using anti-vGLUT1 and anti-vGAT antibodies, followed by Alex Fluor 488 or 568 labeled secondary antibodies, respectively. …”

The decreased survival of quiescent cells deprived of Sub1 does not depend on strain genotypes or medium composition. by Joël Acker (678056)

Image_2_EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis.TIF by Santiago Castro-Zaballa (6238823)

“…Because of this fact, REM sleep is considered a natural model of psychosis. Ketamine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist that at sub-anesthetic dose induces psychotomimetic-like effects in humans and animals, and is employed as a pharmacological model of psychosis. …”

Image_1_EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis.TIF by Santiago Castro-Zaballa (6238823)

“…Because of this fact, REM sleep is considered a natural model of psychosis. Ketamine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist that at sub-anesthetic dose induces psychotomimetic-like effects in humans and animals, and is employed as a pharmacological model of psychosis. …”